[1]
“TREATMENT OF PATISIRAN IN PATIENTS WHO HAS TRANSTHYRETIN CARDIAC AMYLOIDOSIS”, IJRS, vol. 2, no. 2, pp. 283–292, Feb. 2024, Accessed: Jun. 19, 2026. [Online]. Available: https://www.uzresearchers.com/index.php/ijrs/article/view/2149